Search research articles
Contact Us
Filters
Showing results (161-170 of 189) with videos related to
Page
of 19
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 12, 2017
Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic Leukemia
Betty Ky Hamilton, Lisa Rybicki, Donna Abounader, et al.
Blood Advances
|
January 17, 2025
TP53 mutations are associated with CD19- relapse and inferior outcomes after blinatumomab in adults with ALL
Ibrahim Aldoss, Shanpeng Li, Jianying Zhang, et al.
Research Square
|
August 16, 2024
Anti-CD7 allogeneic WU-CART-007 in patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma: a phase 1/2 trial
Armin Ghobadi, Ibrahim Aldoss, Shannon Maude, et al.
Nature Communications
|
February 20, 2026
Immunometabolic determinants of long-term response in leukemia patients receiving CD19 CAR T cell therapy
Lior Goldberg, Eric R Haas, Jiaqi Wu, et al.
Blood Advances
|
October 15, 2020
TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML
Jayakumar Vadakekolathu, Catherine Lai, Stephen Reeder, et al.
Haematologica
|
November 7, 2024
Venetoclax in combination with a pediatric-inspired regimen for the treatment of newly diagnosed adults with Philadelphia chromosome-negative acute lymphoblastic leukemia
Ibrahim Aldoss, Jianying Zhang, Kathryn Shimamoto, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 16, 2024
Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Bijal Shah, Ryan J Mattison, Ramzi Abboud, et al.
Transplantation and Cellular Therapy
|
March 30, 2026
Disability-Free Survival: A Novel Morbidity Endpoint for Older Adult Allogeneic Hematopoietic Cell Transplantation
Jorge M Ramos Perez, Haoyue Shan, Dongyun Yang, et al.
Blood
|
May 30, 2025
Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignancies
Armin Ghobadi, Ibrahim Aldoss, Shannon L Maude, et al.
Blood Advances
|
June 24, 2026
CAR T Cell Therapy as a Definitive Consolidation for Older Adults with B-ALL in First Complete Remission
Ibrahim Aldoss, Lior Goldberg, Jianying Zhang, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 189) with videos related to
Sort By:
Page
of 19
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 12, 2017
Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic Leukemia
Betty Ky Hamilton, Lisa Rybicki, Donna Abounader, et al.
Blood Advances
|
January 17, 2025
TP53 mutations are associated with CD19- relapse and inferior outcomes after blinatumomab in adults with ALL
Ibrahim Aldoss, Shanpeng Li, Jianying Zhang, et al.
Research Square
|
August 16, 2024
Anti-CD7 allogeneic WU-CART-007 in patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma: a phase 1/2 trial
Armin Ghobadi, Ibrahim Aldoss, Shannon Maude, et al.
Nature Communications
|
February 20, 2026
Immunometabolic determinants of long-term response in leukemia patients receiving CD19 CAR T cell therapy
Lior Goldberg, Eric R Haas, Jiaqi Wu, et al.
Blood Advances
|
October 15, 2020
TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML
Jayakumar Vadakekolathu, Catherine Lai, Stephen Reeder, et al.
Haematologica
|
November 7, 2024
Venetoclax in combination with a pediatric-inspired regimen for the treatment of newly diagnosed adults with Philadelphia chromosome-negative acute lymphoblastic leukemia
Ibrahim Aldoss, Jianying Zhang, Kathryn Shimamoto, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 16, 2024
Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Bijal Shah, Ryan J Mattison, Ramzi Abboud, et al.
Transplantation and Cellular Therapy
|
March 30, 2026
Disability-Free Survival: A Novel Morbidity Endpoint for Older Adult Allogeneic Hematopoietic Cell Transplantation
Jorge M Ramos Perez, Haoyue Shan, Dongyun Yang, et al.
Blood
|
May 30, 2025
Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignancies
Armin Ghobadi, Ibrahim Aldoss, Shannon L Maude, et al.
Blood Advances
|
June 24, 2026
CAR T Cell Therapy as a Definitive Consolidation for Older Adults with B-ALL in First Complete Remission
Ibrahim Aldoss, Lior Goldberg, Jianying Zhang, et al.
Page
of 19